Efficacy of thiamine supplementation in improving depressive symptoms - evidence-based review
Keywords:
Thiamine, Depression, Depressive SymptomsAbstract
Title: Efficacy of thiamine supplementation in improving depressive symptoms - Evidence-Based Review
Objective: to review the existing evidence regarding the effectiveness of thiamine supplementation in improving depressive symptoms in adult patients, compared to taking psychoactive drugs alone or placebo.
Design: Systematic Review
Site: Primary Care
Methods: Research question: Population – Adults with depressive symptoms; Intervention – Thiamine supplementation alone or associated with psychotropic drugs; Comparison: use of placebo or psychotropic drugs; Outcome – Improvement of depressive symptoms (according to DSM-V). The search was performed using the MeSH terms (("Depression" OR "Depression Disorder") AND "Thiamine"") in the selected sources. All opinion articles, classic review articles, and studies already included in meta-analyses or previously selected reviews were excluded. The strength of recommendation taxonomy scale (SORT) was used to assign levels of evidence and strength of recommendation.
Results: The search resulted in 3 articles that met the inclusion criteria, from which conclusions were drawn.
Conclusions: Statistically significant benefits of thiamine supplementation were demonstrated in some of the evaluated parameters, namely psychomotor slowing, mood, appetite/body weight, feeling of fatigue, and an acceleration of the pharmacological response with its concomitant use with Fluoxetine 20 mg. Thus, thiamine supplementation was assigned a Strength of Recommendation B by the SORT Scale, as existing studies of moderate quality are few, albeit patient oriented.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Cadernos de atencion primaria
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
This journal is publish under a license
CC Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)